<SEC-DOCUMENT>0001144204-16-082105.txt : 20160216
<SEC-HEADER>0001144204-16-082105.hdr.sgml : 20160215
<ACCEPTANCE-DATETIME>20160216100831
ACCESSION NUMBER:		0001144204-16-082105
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160216
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160216
DATE AS OF CHANGE:		20160216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11634
		FILM NUMBER:		161424125

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v431941_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Pursuant to Section&nbsp;13 or 15(d) of
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 67%; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of Report (Date of Earliest Event Reported):</FONT></TD>
    <TD STYLE="text-align: center; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 16, 2016</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 18pt">STAAR Surgical
Company</FONT><BR>
<FONT STYLE="font-size: 10pt">__________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delaware</U></FONT></TD>
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>0-11634</U></FONT></TD>
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>95-3797439</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of incorporation)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>1911 Walker Ave, Monrovia, California</U></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>91016</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 0.25in; width: 67%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s telephone number, including area code:</FONT></TD>
    <TD STYLE="text-align: center; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">626-303-7902</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Not Applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Former name or former address, if changed
since last report</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.4pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.4pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.4pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><B>Item 7.01 Regulation FD Disclosure. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">STAAR
Surgical Company issued a press release regarding a cooperation agreement with a customer, Aier Eye Hospital Group Co. Ltd. A copy
of the press release is furnished as Exhibit 99.1 to this Report, and is incorporated herein by this reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be
&ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the
date of this Current Report, regardless of any general incorporation language in the filing</FONT>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 9.01</B></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 0.5in; text-indent: 0.5in">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline; font-size: 10pt; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit No.</U></B></FONT></TD>
    <TD STYLE="text-decoration: underline; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Description</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;99.1</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated February 16, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STAAR Surgical Company&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 16, 2016</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 82%; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>/s/ Caren Mason</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caren Mason</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v431941_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 48.75pt; width: 117pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STAAR Surgical and Aier Eye Hospital
Group Announce Strategic Cooperation Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Agreement Addresses Significant Need
for Refractive Surgery in Chinese Population with Mid to High Myopic Correction Requirements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>MONROVIA, CA, February 16, 2016</B>---STAAR
Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the
eye, and Aier Eye Hospital Group Co. Ltd. <FONT STYLE="background-color: white">(SHE: 300015)</FONT><FONT STYLE="text-transform: uppercase">,
</FONT>the largest refractive surgery provider in China<FONT STYLE="text-transform: uppercase">, </FONT>today announced they have
entered into an agreement to provide STAAR&rsquo;s CentraFLOW&reg; intraocular lenses (ICL) as a primary and premium option for
refractive eye treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;Aier Eye Hospital Group is dedicated
to providing our patients with exceptional refractive vision care solutions. We currently operate 100 eye hospitals with a strategic
plan to grow to over 200 eye hospitals by 2020. This growth is necessary to be able to provide the very large number of patients
with the opportunity for the best myopic correction possible,&rdquo; said Mr. Li Li, CEO of Aier Eye Hospital Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">According to <I>A Research Report
on the Vision Health of Chinese People</I>, authored by the China Health Development Research Center, Peking University, published
on June 12, 2015, &ldquo;The number of people with high myopia alone is far greater than the totality of those with other types
of vision defects. Myopia is particularly widespread among teenagers. It is estimated that in 2012, there were totally 480 to
531 million people suffering from myopia, with as many as 29 to 30.4 million having high myopia.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;We believe that our partnership
with STAAR will provide a strong collaboration projected to include surgeon training, clinical studies, patient registries, local
inventory including the more custom Toric lenses, patient information both in person and through digital communications and an
ability to meet patient demand within the day of interest. All of these partnership terms are significant and very important to
make the ICL a primary and premium treatment option for our mid to high myopic patients. We will also be an enthusiastic clinical
contributor to the STAAR Asia Experts Meeting in Shanghai in March,&rdquo; concluded Mr. Li Li.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;STAAR is pleased to have entered
into a Strategic Cooperation Agreement with Aier Hospital Group where the CentraFLOW Visian implantable Collamer&reg; lens will
be positioned as a primary and premium vision correction solution for their patients. Our distributor, Shanghai Lansheng Resources
Co. Ltd, has expanded to specialized distribution with a dedicated ICL division and has partnered with us to provide Aier Eye Hospital
Group with close cooperation and committed levels of support as contracted lens purchase unit milestones are achieved. STAAR considers
cooperation and strategic agreements as fundamental to its transformational goal to provide outstanding vision care experience
and outcome for patients with exceptional clinical support as a core tenet&rdquo; said Caren Mason, President &amp; CEO of STAAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><I><U>About STAAR Surgical</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">STAAR, which has been dedicated solely
to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye with companion
delivery systems. These lenses are intended to provide visual freedom for patients lessening or eliminating the reliance on glasses
or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR&rsquo;s
lens used in refractive surgery is called an Implantable Collamer&reg; Lens or &ldquo;ICL&rdquo;. More than 550,000 Visian ICLs
have been implanted to date. To learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 employees and
markets lenses in over 60 countries. Headquartered in Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo,
CA and Monrovia, CA. For more information, please visit the Company&rsquo;s website at <U>www.staar.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>Safe Harbor</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All statements in this press release that are not statements
of historical fact are forward-looking statements, including statements about any of the following: statements regarding products
or potential future sales in China, including but not limited to sales to Aier Eye Hospital Group, current or future and any statements
of assumptions underlying any of the foregoing. Important factors that could cause actual results to differ materially from those
indicated by such forward-looking statements are set forth in the Company&rsquo;s Annual Report on Form 10-K for the year ended
January 2, 2015, under the caption &ldquo;Risk Factors&rdquo;, which is on file with the Securities and Exchange Commission and
available in the &ldquo;Investor Information&rdquo; section of the company&rsquo;s website under the heading &ldquo;SEC Filings.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These statements are based on expectations and assumptions as
of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ
materially from those described in the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTACT:</FONT></TD>
    <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investors</B></FONT></TD>
    <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVC Group</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVC Group</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Moore, 310-579-6199</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave Schemelia, 646-445-4800</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug Sherk, 415-652-9100</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "5 68# 2(  A$! Q$!_\0
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M6LZ=/:,>!(GSQG\?_P!=+G74?*SI**J6>J6&H+FTNXI?96Y'X=:MU1(4444
M%%%% !5=91_:,D.>?*5OU858K%CN@?&<UMGI9*?QWG_&DW8:-JBBBF(****
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M[:(3=O4JZ7I-II-OY5LGS-R\C<LY]2:O445JE8@**** "BBB@ HHHH ****
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M=8__ $*LOX-_\B_J'_7U_P"R"M3XI_\ (BW'_76/_P!"K+^#?_(OZA_U]?\
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MKGTFN9/$M]9OJ$T=O%"LB !/E)Z\E:&[ D=!16-X?U"YOA>I,XFC@G,<5P%
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MU<V.A2W5K.T4L97! !SE@.<CWK8C4I&JEV<@?>;&3^5%];#L.HHHIB"BBB@
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K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
